Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Grows By 284.7%

Biomerica, Inc. (NASDAQ:BMRA) was the target of a large increase in short interest in November. As of November 30th, there was short interest totalling 1,430,000 shares, an increase of 284.7% from the November 15th total of 371,700 shares. Based on an average trading volume of 844,900 shares, the short-interest ratio is currently 1.7 days.

Institutional Investors Weigh In On Biomerica

An institutional investor recently bought a new position in Biomerica stock. Perritt Capital Management Inc acquired a new stake in Biomerica, Inc. (NASDAQ:BMRA) during the second quarter, according to its most recent 13F filing with the SEC. The fund acquired 70,000 shares of the company’s stock, valued at approximately $31,000. Perritt Capital Management Inc owned 0.42% of Biomerica as of its most recent filing with the SEC. 22.28% of the stock is owned by institutional investors.

Biomerica Stock Down 3.4 %

NASDAQ:BMRA traded down $0.01 during trading hours on Wednesday, hitting $0.29. 144,084 shares of the company traded hands, compared to its average volume of 408,170. The firm’s 50-day simple moving average is $0.34 and its 200-day simple moving average is $0.38. Biomerica has a one year low of $0.24 and a one year high of $2.13. The company has a market cap of $4.88 million, a PE ratio of -0.81 and a beta of -1.10.

Biomerica (NASDAQ:BMRA) last released its earnings results on Tuesday, October 15th. The company reported ($0.08) EPS for the quarter. The business had revenue of $1.81 million for the quarter. Biomerica had a negative return on equity of 84.62% and a negative net margin of 111.89%.

Biomerica Company Profile

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.